Skip to main content
Caplight Logo









Auristone

Auristone

Private
SingaporeHealthcare & Life Scienceshttps://auristone.com/

Last Round

Seed

Apr 2, 2024

Total Funding Raised

$4M

Company Overview

Auristone is a biotechnology company that provides epigenomic profiling services and predictive models to support precision oncology and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

epigenomic profilingprecision medicineNGSnext-generation sequencingcancer diagnosticsimmunotherapy responsebioinformaticsmolecular profilingepigeneticsclinical decision supportLDTlaboratory developed testChIP-SeqRNA-Seqbiotechoncology researchmulti-omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Auristone Comparables

Compare Auristone with similar companies based on industry and business-model similarity.

Auristone comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Precede Biosciences
77%
Lucence
76%
OXFORD BIODYNAMICS LS-01
73%

Auristone Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 2, 2024
SeedAug 1, 2021

Key People

Founding team and executive leadership

Jingming Chew

Co-Founder and CEO

Founding Team

Auristone Investors

Notable investors and investment history

Auristone investors
InvestorRounds
SEEDS CapitalSeed
Elev8.vcSeed
GenedantSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors grew 140% MoM, reaching 884.

  • Feb 3, 2026

    Grew 25% QoQ, from 12 to 15 employees.

Auristone Filings

Explore SEC and related filing metadata, where available.

Auristone filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Auristone's valuation, stock price, and market status.

Is Auristone a public or private company?

Auristone is a private company.

What is the current stock price of Auristone?

Auristone is a private company with no public stock price. No recent secondary market data is available.

How much is Auristone worth (valuation)?

Valuation information for Auristone is not publicly available.

Can I buy Auristone stock?

Auristone shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Auristone's last funding round?

Auristone's most recent funding round was Seed on April 2, 2024.

Who are the main investors in Auristone?

Key investors in Auristone include Elev8.vc.

Will Auristone IPO soon?

No public IPO plans have been announced for Auristone.

How can I track Auristone secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Auristone's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range13
Year Founded2021
Last FundingApr 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?